Skip to content

A randomized control trial comparing sterile water and chlorhexidine aqueous 0.5% as cleansing agent for clean intermittent self-catheterization (CIC) for patient with neurogenic bladder in children.

A randomized control trial comparing urinary tract infection rates with sterile water versus chlorhexidine aqueous 0.5% as cleansing agent for clean intermittent self-catheterization (CIC) in children with neurogenic bladder.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001752257
Enrollment
46
Registered
2018-10-24
Start date
2018-02-22
Completion date
2018-10-25
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A randomized control trial comparing sterile water and chlorhexidine 0.5% aqueous as cleansing agent for clean intermittent self-catheterization (CIC) for patient with neurogenic bladder in children. Neurogenic bladder is a disorder of the lower urinary tract due to damage or diseases of the nervous system. It can be either congenital or acquired. Neurogenic bladder can lead to problematic symptoms and complications including urinary incontinence, frequency, and urgency, along with risk for infection and involvement of the upper urinary tract and kidney disease. Purpose: To compare the prevalence of urinary tract infection in patient clean self-catheterization using sterile water and chlorhexidine aqueous 0.5% as cleaning agent. Hypothesis: There are no increase risk of urinary tract infection in group using sterile water as cleansing agent before CIC. This is randomized control trial study involving pediatric patient with neurogenic bladder. Patient will be divide in to 2 groups, 1st is control group whereby they will use chlorhexidine aqueous 0.5% as cleansing agent and intervention group is using sterile water as cleansing agent. Study period is 2 weeks or if patient develop complication such as urinary tract infection. At the end of study, Urine sample will be collected and send for urinalysis and urine culture.

Interventions

Patient will be divided into two arms. Arm 1: Using Chlorhexidine aqueous 0.5% as cleansing agent before procedure clean intermittent self-catheterization (CIC). This is a control group. Arm 2: Using sterile water as cleansing agent before procedure CIC. This is an intervention group. All patient / caretaker will be teach regarding CIC technique during clinic visit. Patient will be divide into group by choosing opaque envelop which contain group assignment. Randomization done by third party

Patient will be divided into two arms. Arm 1: Using Chlorhexidine aqueous 0.5% as cleansing agent before procedure clean intermittent self-catheterization (CIC). This is a control group. Arm 2: Using sterile water as cleansing agent before procedure CIC. This is an intervention group. All patient / caretaker will be teach regarding CIC technique during clinic visit. Patient will be divide into group by choosing opaque envelop which contain group assignment. Randomization done by third party via computer generated randomization. Material for intervention is a sterile water. 20 ml of sterile water is used to clean the urethra orifice using the three clean cotton wool. Meanwhile for control group is 20 ml of chlorhexidine aqueous 0.5% is used to clean the urethra orifice before CIC . Procedure CIC will be teach by investigator during clinic visit. Investigator has 7 years experiences in paediatric fraternity. Mode of teaching is via face to face learning. Number of teaching is once during clinic visit before the starting the study. This is because all patients/parents were taught before the initiation of CIC procedure. Frequency of CIC is 4-5 times per day. Patient and parents are advised to adhere to frequency of doing CIC at home. Adherence to frequency of CIC is monitored by own diary and shown to investigator during clinic visit for urine sampling.

Sponsors

Malaysian University Science Hospital
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention

Eligibility

Sex/Gender
All
Age
1 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

Patient with neurogenic bladder on regular CIC at least >3x per day age 1-17 years old.

Exclusion criteria

1. patient/ parents refused to take part 2. average frequency of CIC < 3x per day 3. recent history of taking antibiotics for any infection.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026